What you should know about paracetamol and COVID-19

What the experts are saying
World Health Organisation (WHO)
The WHO continue to include paracetamol within their essential package of palliative care for prevention and relief of pain or other physical suffering, acute or chronic, related to COVID-19.https://www.who.int/publications/i/item/clinical-management-of-covid-19
European Medicines Agency
“When starting treatment for fever or pain in COVID-19, patients and healthcare professionals should consider all available treatment options including paracetamol and NSAIDs. Each medicine has its own benefits and risks which are reflected in its product information and which should be considered along with EU national treatment guidelines, most of which recommend paracetamol as a first treatment option for fever or pain.”https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19
National Institute for Health and Care Excellence (NICE)
“Advise patients to take paracetamol or ibuprofen if they have fever and other symptoms that antipyretics would help treat.”https://www.nice.org.uk/guidance/ng163/chapter/5-Managing-fever accessed 22 October 2020
Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic, research paper
“Paracetamol should be the first analgesic that dentists recommend…Paracetamol is a drug with an established safety profile at recommended doses.”https://pubmed.ncbi.nlm.nih.gov/32651512/

Sign up
For news, updates, and more, click the link below to sign up and be on our mailing list